Mcneil Laboratories

J&J's QA Initiative and Settlement Could See Troubled Plant Reopen

23-Jul-2013 By Dan Stanton

Johnson & Johnson’s troubled Fort Washington plant may reopen early next year, says the firm following a $23m lawsuit settlement.

Another J&J Tylenol recall

07-Jul-2011 By Natalie Morrison

Tylenol Extra Strength Caplets yesterday became the latest in a long succession of Johnson & Johnson products to be pulled from the shelves after complaints of the pills’ “musty odor”.

Johnson & Johnson finalises terms of FDA consent decree

16-Mar-2011 By Alexandria Pesic

Johnson & Johnson, the multinational healthcare giant, has announced it has finalised the terms of a consent decree with the FDA over its stricken McNeil PPC manufacturing plants.

J&J recall 9m more Tylenol bottles

29-Nov-2010

Johnson & Johnson is recalling a further 9m Tylenol bottles in the US after learning of inconsistencies in product label warnings.

J&J’s musty-smelling Tylenol is recalled again

20-Oct-2010 By Alexandria Pešić

Johnson & Johnson (J&J) recalls another 128,000 bottles of its over-the-counter painkiller, Tylenol, after new complaints of a “mouldy odour.”

J&J halts production at Pennsylvania after FDA QC criticism

06-May-2010 By Gareth Macdonald

Healthcare major Johnson & Johnson (J&J) has suspended operations at a Pennsylvania plant linked to a major product recall after US FDA inspection.